Ipamorelin Peptide

Molecular strand with red particles and chemical structures, relevant to peptide science.

WARNING: This content is provided strictly for educational and scientific research purposes. Ipamorelin is supplied as a chemical standard for Research Use Only (RUO). It is NOT intended for human consumption, clinical treatment, diagnostic use, or veterinary application. Any biological activity described refers exclusively to in vitro or animal model research.

Ipamorelin Peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2): Pharmacodynamics, Selectivity & Research Profile

Ipamorelin peptide is a highly selective synthetic growth hormone secretagogue widely used as a research peptide and laboratory chemical standard. Due to its clean pharmacological profile and strong affinity for the GHS-R1a receptor, Ipamorelin is frequently employed in endocrine signaling studies, GH-axis modeling, receptor pharmacology, and comparative peptide research.

Researchers sourcing Ipamorelin for laboratory research typically require high analytical purity, batch-to-batch consistency, and validated documentation such as HPLC and mass spectrometry analysis to ensure reproducible experimental outcomes.

Ipamorelin peptide molecular structure showing pentapeptide sequence and selective binding to the GHS-R1a growth hormone secretagogue receptor for research use only

Introduction to the Ipamorelin Pentapeptide Structure

Ipamorelin belongs to the third generation of synthetic Growth Hormone Releasing Peptides (GHRPs). Unlike earlier secretagogues, Ipamorelin was specifically engineered to stimulate growth hormone (GH) release without activating stress-related hormonal pathways such as cortisol or prolactin secretion.

The peptide sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 confers enhanced stability, receptor selectivity, and resistance to enzymatic degradation, making Ipamorelin a preferred compound for controlled endocrine research.

  • Aib (α-aminoisobutyric acid): Enhances resistance to aminopeptidase degradation.
  • D-2-Nal: Improves hydrophobic receptor binding within GHS-R1a.
  • C-terminal amidation: Protects against carboxypeptidase cleavage.

Chemical Specifications (Laboratory Verification)

  • CAS Number: 170851-70-4
  • Molecular Formula: C38H49N9O5
  • Molecular Weight: 711.85 Da
  • Isoelectric Point: ~9.8
  • Purity: ≥98% (HPLC, ESI-MS verified)

For laboratories requiring consistent experimental conditions, sourcing Ipamorelin research peptide from specialized suppliers such as PeptidesSkin ensures access to analytical documentation suitable for academic and industrial research settings.

Mechanism of Action: Selective GHS-R1a Agonism

Ipamorelin exerts its effects through high-affinity binding to the Growth Hormone Secretagogue Receptor type 1a (GHS-R1a), a G-protein coupled receptor expressed in the hypothalamus and anterior pituitary.

Upon receptor activation, Ipamorelin triggers the phospholipase C (PLC) signaling cascade, leading to IP3-mediated calcium mobilization and protein kinase C (PKC) activation. This signaling pathway culminates in controlled exocytosis of GH-containing vesicles.

Comparative Selectivity: A Clean Research Secretagogue

Unlike non-selective GHRPs such as GHRP-2 and GHRP-6, Ipamorelin does not significantly stimulate ACTH, cortisol, or prolactin release. This clean selectivity profile makes it a valuable tool for isolating somatotropic axis activity in endocrine and metabolic research.

Pharmacokinetics and Pharmacodynamics (Research Models)

  • Tmax: ~40 minutes
  • Plasma half-life: ~2 hours
  • GH response: Linear dose-dependent up to receptor saturation

The predictable PK/PD behavior of Ipamorelin allows precise modulation of GH levels in animal and in vitro experimental designs.

Physiological Outcomes Observed in Research Studies

  • Increased IGF-1 mediated bone growth in rodent models
  • Positive nitrogen balance and anabolic signaling
  • Improved clarity of GH-driven metabolic outcomes due to cortisol independence

Future Research Applications

Ongoing research explores Ipamorelin’s potential role in gastrointestinal motility models, aging-related GH decline studies, and comparative secretagogue pharmacology. Its safety and selectivity profile continue to position Ipamorelin as a reference compound in growth hormone research.

Frequently Asked Questions (Research Use Only)

Is Ipamorelin approved for human use?

No. Ipamorelin is strictly sold as a research chemical and laboratory standard (RUO).

Can Ipamorelin be used in cell culture experiments?

Yes. Ipamorelin is suitable for in vitro studies when properly dissolved and sterile-filtered.

How is purity verified?

Purity is confirmed using HPLC and mass spectrometry analysis.

Research Use Only: Ipamorelin is intended exclusively for laboratory research and analytical applications. Researchers seeking high-purity peptides with documented quality standards may consult specialized peptide research platforms for further information.